VijayPD Ceutical Peer Comparison

NSE: VIJAYPD

₹69.75

₹-7.75 (-10.00%)

As on 11-Nov-2026IST

Market cap

₹136 Cr

Revenue (TTM)

₹100 Cr

P/E Ratio

27.2

P/B Ratio

2.6

Div. Yield

0 %

Edit

	VijayPD Ceutical	Entero Health	Bio Medica Laboratories	Speciality Medicines	Goldline Pharmaceutical
Market cap (₹ Cr)	136	8,733	189	141	29
Revenue (₹ Cr)	100	7,644	43	75	31
Net Profit (₹ Cr)	5.00	191.80	11.89	13.03	4.12
Net Margin (%)	4.79	2.50	27.57	17.12	13.20
RoE (%)	9.53	8.35	57.64	25.60	39.41
Price to Earnings	27.24	62.67	16.00	10.85	7.11
Price-To-Book	2.60	4.91	6.30	1.99	1.22

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	VijayPD Ceutical	Entero Health	Bio Medica Laboratories	Speciality Medicines	Goldline Pharmaceutical
Operating Revenue	100.23	6,591.21	43.09	75.29	31.20
Total Income	104.35	6,610.45	43.11	76.11	31.20
Total Expenditure	95.56	6,325.26	23.11	61.60	24.12
EBITDA	4.67	265.96	19.98	13.68	7.08
Depreciation	0.65	43.29	1.16	0.17	0.24
EBIT	4.02	222.66	18.81	13.51	6.84
Interest	1.66	54.39	2.58	1.32	1.46
Other Income	4.12	19.24	0.02	0.83	0.00
Exceptional Items	-0.01	-8.18	--	--	--
Profit before Tax	6.47	179.34	16.25	13.02	5.39
Provision for Tax	1.47	33.50	4.37	-0.01	1.27
Profit after Tax	5.00	145.84	11.89	13.03	4.12

Liabilities (₹ Cr)

	VijayPD Ceutical	Entero Health	Bio Medica Laboratories	Speciality Medicines	Goldline Pharmaceutical
Shareholder's Funds	52.48	1,688.61	26.51	71.19	14.25
Minority Interest	-0.08	63.94	-6.17	--	--
Non-Current Liabilities	4.66	206.12	33.45	5.15	2.43
Current Liabilities	42.23	1,587.57	19.18	18.88	12.11
Total Liabilities	99.64	3,600.22	73.31	95.22	28.87

Assets (₹ Cr)

	VijayPD Ceutical	Entero Health	Bio Medica Laboratories	Speciality Medicines	Goldline Pharmaceutical
Non-Current Assets	23.77	1,037.80	18.31	6.26	2.75
Current Assets	75.53	2,503.13	54.67	88.97	26.05
Total Assets	99.64	3,600.22	73.31	95.22	28.87
Total Debt*	36.71	566.68	39.99	6.64	9.16
Net Current Assets	33.30	915.56	35.48	70.09	13.93
Contingent Liabilities	0.14	5.51	--	--	3.37

Cashflow (₹ Cr)

	VijayPD Ceutical	Entero Health	Bio Medica Laboratories	Speciality Medicines	Goldline Pharmaceutical
Cash From Operating Activities	-8.61	96.20	-6.03	-1.28	2.81
Cash Flow from Investing Activities	-13.33	-303.06	-2.31	-2.83	-0.06
Cash from Financing Activities	31.59	123.66	8.43	27.82	-3.40
Net Cash Inflow / Outflow	9.65	-83.20	0.09	23.70	-0.65

Ratios

Profitability Ratios

	VijayPD Ceutical	Entero Health	Bio Medica Laboratories	Speciality Medicines	Goldline Pharmaceutical
ROCE (%)	9.12	10.93	39.14	25.26	30.60
ROE (%)	9.53	8.57	57.64	25.60	39.41
ROA (%)	5.04	4.68	21.33	19.27	14.98
EBIT Margin (%)	8.77	4.33	46.41	19.27	22.70
Net Margin (%)	4.79	2.21	27.57	17.12	13.20
Cash Profit Margin (%)	5.64	2.87	30.29	17.54	13.97

Growth Ratios

	VijayPD Ceutical	Entero Health	Bio Medica Laboratories	Speciality Medicines	Goldline Pharmaceutical
Revenue Growth (%)	0.00	29.35	12.45	29.20	11.20
EBIT Growth (%)	--	35.13	29.01	54.39	16.95
Net Profit Growth (%)	0.00	35.75	22.50	81.11	45.26
EPS Growth (%)	0.00	21.32	21.40	32.67	45.26
Book Value Growth (%)	0.00	-2.19	79.96	132.49	47.19

Valuation Ratios

	VijayPD Ceutical	Entero Health	Bio Medica Laboratories	Speciality Medicines	Goldline Pharmaceutical
Price / Earnings	25.46	47.12	0.00	8.49	0.00
Price / Book Value	2.43	3.22	0.00	1.55	0.00
Dividend Yield (%)	0.00	0.00	--	0.00	--
EV/EBITDA	16.66	20.43	2.45	6.39	2.44
Market Cap (₹ Cr)	127.33	5,420.61	0.00	110.62	0.00

Solvency Ratios

	VijayPD Ceutical	Entero Health	Bio Medica Laboratories	Speciality Medicines	Goldline Pharmaceutical
Debt to Equity	0.70	0.34	1.51	0.09	0.64
Short term debt to equity ratio	0.48	0.26	0.22	0.01	0.42
Current Ratio	1.79	1.58	2.85	4.71	2.15
Quick Ratio	1.49	1.05	0.95	3.21	1.64
Interest Coverage	4.89	4.30	7.29	10.87	4.70

Operating Efficiency Ratios

	VijayPD Ceutical	Entero Health	Bio Medica Laboratories	Speciality Medicines	Goldline Pharmaceutical
Debtors to sales (%)	30.52	18.39	25.19	35.20	51.70
Asset Turnover	1.01	2.11	0.77	1.11	1.13
Receivable days	111.39	56.56	63.33	87.52	156.90
Inventory Days	45.39	41.57	230.85	110.76	75.99
Payable days	32.72	34.66	181.09	43.45	64.86
Cash Conversion Cycle	124.06	63.47	113.10	154.84	168.03